Expression profile of nuclear receptors upon Epstein - Barr virus induced B cell transformation

Experimental Oncology

Volumn 31, Issue 2, 2009, Pages 92-96

  Yenamandra, S P ^a   Lundin, A ^a   Arulampalam, V ^a   Yurchenko, M ^b   Pettersson, S ^a   Klein, G ^a   Kashuba, E ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Cell transformation; EBV; Expression pattern; Microarrays; Nuclear receptors

Indexed keywords

CELL NUCLEUS RECEPTOR; EPSTEIN BARR VIRUS ANTIGEN; MESSENGER RNA; NUCLEAR RECEPTOR NUR77; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CELL RECEPTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE TRANSFORMATION; MICROFLUIDIC ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; VIRUS CELL TRANSFORMATION; CELL TRANSFORMATION; GENE EXPRESSION; GENETICS; METABOLISM; VIROLOGY; VIRUS INFECTION; WESTERN BLOTTING;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 68849103189     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kieff E, Rikinson A. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia: Lippincott Williams&Wilkins, 2001: 2511-2574
2. Rikinson A, Kieff E. Epstein - Barr virus. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia: Lippincott Williams&Wilkins, 2001: 2575-2628
3. Tomkinson B, Robertson E, Kieff E. Epstein - Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 1993; 67: 2014-2025 (Pubitemid 23088375)
4. Yenamandra SP, Klein G, Kashuba E. Nuclear receptors and their role in Epstein - Barr virus induced B cell transformation. Exp Oncol 2009; 31: 67-73.
5. Mattsson K, Pokrovskaja K, Kiss C, et al. Ptroteins associated with the PMNL-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci USA 2001; 98: 1012-1017 (Pubitemid 32121178)
6. Brennan P. Signalling events regulating lymphoid growth and survival. Semin Cancer Biol 2001; 11: 415-421 (Pubitemid 33105020)
7. Lee JM, Lee KH, Weidner M, et al. Epstein - Barr virus EBNA2 blocks Nur77-mediated apoptosis. Proc Natl Acad Sci USA 2002; 99: 11878-11883 (Pubitemid 34994492)
8. Lee JM, Lee KH, Farrell CJ, et al. EBNA2 is required for protection of latently Epstein - Barr virus-infected B cells against specific apoptotic stimuli. J Virol 2004; 78: 12694-12697
9. Horndasch M, Raschke EE, Bommer G, et al. Epstein - Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling. Int J Cancer 2002; 101: 442-447 (Pubitemid 35050685)
10. Kashuba EV, Gradin K, Isaguliants M, et al. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem 2006; 281: 1215-1223
11. Sista ND, Pagano JS, Liao W, et al. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci USA 1993; 90: 3894-3898 (Pubitemid 23134132)
12. Sista ND, Barry C, Sampson K, et al. Physical and functional interaction of the Epstein - Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha. Nucleic Acids Res 1995; 23: 1729-1736
13. Lomo J, Smeland EB, Ulven S, et al. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 1998; 175: 68-77. (Pubitemid 28101973)
14. Morgan JW, Reddy GS, Uskokovic MR, et al. Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes. J Biol Chem 1994; 269: 13437-13443 (Pubitemid 2078436)
15. Elstner E, Lee YY, Hashiya M, et al. 1-alpha,25-Dihydroxy- 20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 1994; 84: 1960-1967 (Pubitemid 24286148)
16. Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296: 1313-1316 (Pubitemid 34522785)
17. Gombart AF, Luong QT, Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res 2006; 26: 2531-2542 (Pubitemid 44155532)
18. Norman AW. Vitamin D Receptor (VDR): New assignments for an already busy receptor. Endocrinology 2006; 147: 5542-5548
19. Jones DC, Ding X, and Daynes RA. Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 2002; 277: 6838-6845
20. Schlezinger JJ, Jensen BA, Mann KK, et al. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells. J Immunol 2002; 169: 6831-6841 (Pubitemid 36899268)
21. Konopleva M, Elstner E, McQueen TJ, et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther 2004; 3: 1249-1262 (Pubitemid 39440170)
22. Welch JS, Ricote M, Akiyama TE, et al. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 2003; 100: 6712-6717 (Pubitemid 36666645)
23. Suzawa M, Takada I, Yanagisawa J, et al. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 2003; 5: 24-30.